Not too unusual story in today's GUARDIAN newspaper. A pharmaceutical company tries to prevent access to a cancer medication it has invented. Ophthalmologists all over the world, according to the paper, noticed that if the company's colon cancer drug is injected into the eyes of patients going blind, remarkable successes can be achieved. The company since has investigated the matter, undertaken clinical trials and wants to prevent doctors from using its cheap cancer drug for non invented for purposes. Instead it wants doctors to prescribe the same drug under a different name and dosage to prevent blindness, at a 100% increased price.
Ein Schelm were boeses dabei denkt...
